NCT03005132Recruiting
Integrative Analysis of Human Glioblastoma Multiforme
Source: ClinicalTrials.gov · Last updated 29 Dec 2016 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Integrative analysis of GBM
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 23 Dec 2016
- Start date
- 1 Jan 2016
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Shanghai 10th People's Hospital
- Diseases
- Glioblastoma
- NCT number
- NCT03005132
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2016 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Prior cancer chemotherapy
Age
- Age ≥ 76
Other
- Severe major organ dysfunction
- WHO performance status of \>1
Who the study is looking for
- Age ≤ 75 years with histologically proven GBM
- No severe major organ dysfunction
- World Health Organization (WHO) performance status of 0 or 1
- No prior cancer chemotherapy
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Tenth People's Hospital Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.